Home > News

13 February 2017

Positve Results From 4th and Final Pivotal Phase 3 Trial of BAREMSIS™ for Rescue Treatment of PONV

12 August 2016

Positve Results From Pivotal Phase 3 Trial of BAREMSIS™ For The Treatment of PONV

21 March 2016

Initiation Of Second Pivotal Phase 3 Treatment Trial With BAREMSIS™ In PONV

05 January 2016

Positive Results From Second Pivotal Phase 3 Prophylaxis Study Of BAREMSIS™ In PONV

03 December 2015

Dr Patrick Vink To Succeed Ian Kent As Non-Executive Chairman

16 October 2015

Postponement of Initial Public Offering

14 September 2015

Announcement of Intention to Float on the London Stock Exchange’s Main Market

06 May 2015

Positive Results From Phase 2 Study With APD403 In CINV

21 April 2015

Phase 3 Combination Prophylaxis Study Initiated With APD421 In PONV

03 March 2015

Scott Byrd and Christine Soden Appointed to Board of Directors

07 October 2014

Acacia Pharma Announces Positive Phase 3 Results for APD421 in PONV

30 October 2013

Phase 2 Study Initiated With APD403 In CINV

15 October 2013

Acacia Pharma Announces Positive Phase 2 Results With APD515 For Xerostomia In Advanced Cancer

17 September 2013

Pivotal Phase 3 Studies Initiated With APD421 in PONV

03 September 2013

Acacia Pharma Raises £15m ($23.5m) To Advance Clinical Development Of Lead Products

01 October 2012

Acacia Pharma Announces Positive Results From Phase 2a Nausea & Vomiting Study In Cancer Patients

12 May 2012

Acacia Pharma Announces Excellent Phase 2 Results For APD421 In PONV

04 January 2012

Phase 2 Study Initiated With APD421 In Post-Operative Nausea & Vomiting (PONV)

06 December 2011

Acacia Pharma Announces Positive Results From Phase IIa Cancer Cachexia Study

25 July 2011

Phase 2 Clinical Trial Initiated With APD515 For Xerostomia

31 March 2011

Acacia Pharma Closes $10 Million Investment Round

16 February 2011

Phase 2a Clinical Trial Initiated With APD421 For Nausea & Vomiting

07 February 2011

Phase 1 Clinical Trial Completed With APD515 For Xerostomia

06 January 2011

Acacia Pharma Starts Clinical Trial With APD515 For Xerostomia

06 January 2011

New Website Launched